Ceftazidime + Tazobactam

Dosage Forms Available

• Ceftazidime + Tazobactam can be administered intravenously (injection or infusion).

Age and Dose Restrictions

• Ceftazidime + Tazobactam is intended for use in adults, adolescents, and children aged 3 months and above.

Contraindications

• This medicine is contraindicated in patients who have previously shown severe hypersensitivity to Ceftazidime, Tazobactam, other cephalosporins, penicillins, or beta-lactamase inhibitors.

Other Medications to Avoid

• Ceftazidime + Tazobactam may interact with uricosurics (such as probenecid).

Overdose and Missed Dose

• An overdose of this medication may cause neurotoxicity (seizures, encephalopathy). If you suspect an overdose, seek immediate medical attention.

• If you forget to administer a dose of this medication, administer it as soon as you remember. However, if it is almost time for the next dose, skip the missed dose.

Management of Side Effects

Most side effects are temporary and generally harmless and resolve when discontinuing this medicine. However, if you experience any severe side effects or worsening of any symptoms, please consult your doctor.

• Increasing fluid intake can help manage gastrointestinal side effects such as diarrhoea.

• Resting in a cool environment can help manage injection site reactions.

Use in Driving and Operating Machinery

• Ceftazidime + Tazobactam may cause dizziness. If you feel dizzy after receiving this medication, avoid driving or operating heavy machinery.

Use in Pregnancy and Lactation

• Ceftazidime + Tazobactam should be used during pregnancy and breastfeeding only if needed. It is advisable to consult your doctor before using this medicine during these times.

Caution in Other Conditions

• Dosage adjustments of Ceftazidime + Tazobactam are necessary for patients with renal impairment, as both Ceftazidime and Tazobactam are primarily eliminated by the kidneys.

Special Dietary and Lifestyle Recommendations

• Ensure proper hygiene practices to prevent further spread of the infection.

• Regular monitoring of kidney function may be required, especially in patients with existing renal conditions or those receiving prolonged therapy.

• Adequate hydration is important as ceftazidime and tazobactam can be excreted via the kidneys. Ensure sufficient fluid intake unless otherwise directed.